MLEC
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Moolec Science SA (MLEC) is rated D+ (1.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Revisions (C+); its weakest is Momentum (F).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-13 | C+ (2.5) | C+ (2.5) | D- (0.8) | F (0.5) | C+ (2.6) | D+ (1.8) |
| 2026-11-06 | C+ (2.5) | C+ (2.5) | D- (0.8) | D- (0.8) | C+ (2.7) | C- (1.9) |
| 2026-10-30 | C+ (2.5) | C+ (2.5) | D- (0.8) | D- (0.7) | C+ (2.7) | D+ (1.8) |
| 2026-10-23 | C+ (2.5) | C+ (2.5) | D- (0.8) | D (1.3) | C+ (2.6) | C- (2.0) |
| 2026-10-16 | C+ (2.5) | C+ (2.5) | D- (0.8) | D- (1.1) | C+ (2.6) | C- (1.9) |